SCHEMBL6952171

SCHEMBL6952171

CCn1c(NC=O)nc(N2CCc3ccccc3CC2)c(C#N)c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.39
ALDH1A1 P00352 9/20 0.38
KDM4E B2RXH2 7/20 0.38
MAPT P10636 5/20 0.38
HPGD P15428 5/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
HTT P42858 4/20 0.38
HSD17B10 Q99714 4/20 0.38
TP53 P04637 2/20 0.38
NPSR1 Q6W5P4 3/20 0.37
POLB P06746 3/20 0.36
MAPK1 P28482 2/20 0.36
TSHR P16473 2/20 0.36
GAA P10253 2/20 0.36
HIF1A Q16665 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
RAB9A P51151 1/20 0.35
PDE7A Q13946 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6947649 0.88 ALDH1A1 (0.41) GRM2ALDH1A1KDM4EMAPTHPGD
SCHEMBL6947679 0.87 MAPT (0.39) GRM2ALDH1A1KDM4EMAPTHPGD
SCHEMBL6952709 0.83 GRM2 (0.42) GRM2ALDH1A1KDM4EMAPTHPGD
SCHEMBL6949441 0.82 ALDH1A1 (0.44) GRM2ALDH1A1KDM4EMAPTHPGD
SCHEMBL6950993 0.79 ALDH1A1 (0.40) GRM2ALDH1A1KDM4EMAPTHPGD
SCHEMBL6955474 0.78 GRM2 (0.39) GRM2ALDH1A1KDM4EMAPTHPGD
SCHEMBL6950036 0.77 ALDH1A1 (0.40) GRM2ALDH1A1KDM4EMAPTHPGD
SCHEMBL6950978 0.77 GRM2 (0.38) GRM2ALDH1A1KDM4EMAPTHPGD
SCHEMBL6952837 0.76 GRM2 (0.43) GRM2ALDH1A1KDM4EMAPTHPGD
SCHEMBL6950841 0.76 ALDH1A1 (0.45) GRM2ALDH1A1KDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed